Skip to content
10-K

Annual Report

IRIS BIOTECHNOLOGIES INC

0001554795-15-000107

← back to feed
Filed
Mar 31, 2015 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2014 · Mar 31, 2015 15.31M sh
Shares Diluted FY 2014 · Dec 31, 2014 16.3M sh
Shares Diluted FY 2014 · Dec 31, 2013 13.83M sh
Operating Cash Flow FY 2014 · Dec 31, 2013 −$245.33K
Current Liabilities FY 2014 · Dec 31, 2013 $191.24K
Total Liabilities FY 2014 · Dec 31, 2013 $207.24K
Current Assets FY 2014 · Dec 31, 2013 $18.99K
Total Assets FY 2014 · Dec 31, 2013 $23.2K
Sga Expense FY 2014 · Dec 31, 2013 $416.97K
Rd Expense FY 2014 · Dec 31, 2013 $59.42K
Net Income FY 2014 · Dec 31, 2013 −$485.54K
Operating Income restated FY 2014 · Dec 31, 2013 −$481.15K
Cash And Equivalents FY 2014 · Dec 31, 2012 $1.04K
Stockholders Equity FY 2014 · Dec 31, 2012 −$119.08K